Literature DB >> 22198674

Generation and characterization of orthotopic murine models for endometrial cancer.

Silvia Cabrera1, Marta Llauradó, Josep Castellví, Yolanda Fernandez, Francesc Alameda, Eva Colás, Anna Ruiz, Andreas Doll, Simó Schwartz, Ramon Carreras, Jordi Xercavins, Miguel Abal, Antonio Gil-Moreno, Jaume Reventós.   

Abstract

We describe the generation of two orthotopic murine models for endometrial cancer (EC).The first model is generated from endometrial Hec-1A cancer cells transfected with luciferase and injected directly into the uterus of female mice. This model allows a follow-up with bioluminescence imaging (BLI) along the experiment and generates abdominal dissemination and lymphatic and hematogenous metastases in high percentages, also detectables with BLI. The dissemination pattern of this model imitates the advanced stages of EC in patients, and its molecular profile corresponds to aggressive type 2 EC (p53 positive, hormone receptors negative, high percentage of Ki67 positive cells). The second model is derived from endometrioid human tissue collected from surgical pieces. By injecting this tissue inside the uterine cavity of a mouse we obtain orthotopic growth with pelvic dissemination and lymph node metastasis. The molecular pattern observed in human type 1 endometrioid EC (p53 negative, low Ki67 index, presence of hormone receptors) is conserved after the murine growth in orthotopic tumor and metastases. This model supposes a singular pre-clinical tool to study therapeutic agents, though it mimics clinical and molecular behavior of endometrioid EC, which is the most common histology in the patient.

Entities:  

Mesh:

Year:  2011        PMID: 22198674     DOI: 10.1007/s10585-011-9444-2

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  24 in total

1.  Natural history of patients with pulmonary metastases from uterine cancer.

Authors:  D Bouros; K Papadakis; N Siafakas; A F Fuller
Journal:  Cancer       Date:  1996-08-01       Impact factor: 6.860

Review 2.  Endometrial carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Authors:  M M Baekelandt; M Castiglione
Journal:  Ann Oncol       Date:  2009-05       Impact factor: 32.976

3.  Pulmonary metastases of endometrial carcinoma.

Authors:  S C Ballon; M L Berman; R C Donaldson; W A Growdon; L D Lagasse
Journal:  Gynecol Oncol       Date:  1979-02       Impact factor: 5.482

Review 4.  Molecular and pathologic aspects of endometrial carcinogenesis.

Authors:  Jonathan L Hecht; George L Mutter
Journal:  J Clin Oncol       Date:  2006-10-10       Impact factor: 44.544

5.  The value of exploratory laparotomy in patients with endometrial carcinoma according to the new International Federation of Gynecology and Obstetrics staging.

Authors:  J R Vardi; G H Tadros; M T Anselmo; S D Rafla
Journal:  Obstet Gynecol       Date:  1992-08       Impact factor: 7.661

Review 6.  Promising novel therapies for the treatment of endometrial cancer.

Authors:  Paola A Gehrig; Victoria L Bae-Jump
Journal:  Gynecol Oncol       Date:  2009-11-10       Impact factor: 5.482

7.  Inhibition of osteopontin suppresses in vitro and in vivo angiogenesis in endometrial cancer.

Authors:  Xue-lian Du; Tao Jiang; Xiu-gui Sheng; Rong Gao; Qing-shui Li
Journal:  Gynecol Oncol       Date:  2009-09-23       Impact factor: 5.482

8.  An orthotopic endometrial cancer mouse model demonstrates a role for RUNX1 in distant metastasis.

Authors:  Andreas Doll; Marta Gonzalez; Miguel Abal; Marta Llaurado; Marina Rigau; Eva Colas; Marta Monge; Jordi Xercavins; Gabriel Capella; Berta Diaz; Antonio Gil-Moreno; Francesc Alameda; Jaume Reventos
Journal:  Int J Cancer       Date:  2009-07-15       Impact factor: 7.396

9.  Clinical and biological significance of vascular endothelial growth factor in endometrial cancer.

Authors:  Aparna A Kamat; William M Merritt; Donna Coffey; Yvonne G Lin; Pooja R Patel; Russell Broaddus; Elizabeth Nugent; Liz Y Han; Charles N Landen; Whitney A Spannuth; Chunhua Lu; Robert L Coleman; David M Gershenson; Anil K Sood
Journal:  Clin Cancer Res       Date:  2007-12-15       Impact factor: 12.531

10.  Prostaglandin F2alpha-F-prostanoid receptor signaling promotes neutrophil chemotaxis via chemokine (C-X-C motif) ligand 1 in endometrial adenocarcinoma.

Authors:  Alison E Wallace; Kurt J Sales; Roberto D Catalano; Richard A Anderson; Alistair R W Williams; Martin R Wilson; Jurgen Schwarze; Hongwei Wang; Adriano G Rossi; Henry N Jabbour
Journal:  Cancer Res       Date:  2009-06-23       Impact factor: 12.701

View more
  11 in total

1.  Nidogen 1 and Nuclear Protein 1: novel targets of ETV5 transcription factor involved in endometrial cancer invasion.

Authors:  Núria Pedrola; Laura Devis; Marta Llauradó; Irene Campoy; Elena Martinez-Garcia; Marta Garcia; Laura Muinelo-Romay; Lorena Alonso-Alconada; Miguel Abal; Francesc Alameda; Gemma Mancebo; Ramon Carreras; Josep Castellví; Sílvia Cabrera; Antonio Gil-Moreno; Xavier Matias-Guiu; Juan L Iovanna; Eva Colas; Jaume Reventós; Anna Ruiz
Journal:  Clin Exp Metastasis       Date:  2015-04-30       Impact factor: 5.150

2.  Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis.

Authors:  Hege F Berg; Marta Espevold Hjelmeland; Hilde Lien; Heidi Espedal; Tina Fonnes; Aashish Srivastava; Tomasz Stokowy; Elin Strand; Olivera Bozickovic; Ingunn M Stefansson; Line Bjørge; Jone Trovik; Ingfrid S Haldorsen; Erling A Hoivik; Camilla Krakstad
Journal:  Commun Med (Lond)       Date:  2021-07-30

Review 3.  Endometrial Cancer Patient-Derived Xenograft Models: A Systematic Review.

Authors:  Tomohito Tanaka; Ruri Nishie; Shoko Ueda; Shunsuke Miyamoto; Sousuke Hashida; Hiromi Konishi; Shinichi Terada; Yuhei Kogata; Hiroshi Sasaki; Satoshi Tsunetoh; Kohei Taniguchi; Kazumasa Komura; Masahide Ohmichi
Journal:  J Clin Med       Date:  2022-05-06       Impact factor: 4.964

4.  ALCAM shedding at the invasive front of the tumor is a marker of myometrial infiltration and promotes invasion in endometrioid endometrial cancer.

Authors:  Jaume Reventos; Antonio Gil-Moreno; Eva Colas; Laura Devis; Elena Martinez-Garcia; Cristian P Moiola; Maria Teresa Quiles; Maria Antonia Arbos; Tomita Vasilica Stirbat; Françoise Brochard-Wyart; Ángel García; Lorena Alonso-Alconada; Miguel Abal; Berta Diaz-Feijoo; William Thomas; Sylvie Dufour; Gemma Mancebo; Francesc Alameda
Journal:  Oncotarget       Date:  2018-03-30

5.  Development of an Image-Guided Orthotopic Xenograft Mouse Model of Endometrial Cancer with Controllable Estrogen Exposure.

Authors:  Gonda Fj Konings; Niina Saarinen; Bert Delvoux; Loes Kooreman; Pasi Koskimies; Camilla Krakstad; Kristine E Fasmer; Ingfrid S Haldorsen; Amina Zaffagnini; Merja R Häkkinen; Seppo Auriola; Ludwig Dubois; Natasja Lieuwes; Frank Verhaegen; Lotte Ejr Schyns; Roy Fpm Kruitwagen; Sofia Xanthoulea; Andrea Romano
Journal:  Int J Mol Sci       Date:  2018-08-28       Impact factor: 5.923

Review 6.  Patient-Derived Xenograft Models for Endometrial Cancer Research.

Authors:  Cristian P Moiola; Carlos Lopez-Gil; Silvia Cabrera; Angel Garcia; Tom Van Nyen; Daniela Annibali; Tina Fonnes; August Vidal; Alberto Villanueva; Xavier Matias-Guiu; Camilla Krakstad; Frédéric Amant; Antonio Gil-Moreno; Eva Colas
Journal:  Int J Mol Sci       Date:  2018-08-17       Impact factor: 5.923

7.  An immune competent orthotopic model of endometrial cancer with metastasis.

Authors:  Alyssa M Fedorko; Tae Hoon Kim; Russell Broaddus; Rosemarie Schmandt; Gadisetti V R Chandramouli; Hong Im Kim; Jae-Wook Jeong; John I Risinger
Journal:  Heliyon       Date:  2020-05-27

Review 8.  Imaging of Preclinical Endometrial Cancer Models for Monitoring Tumor Progression and Response to Targeted Therapy.

Authors:  Heidi Espedal; Tina Fonnes; Kristine E Fasmer; Camilla Krakstad; Ingfrid S Haldorsen
Journal:  Cancers (Basel)       Date:  2019-11-27       Impact factor: 6.639

9.  Multimodal Imaging of Orthotopic Mouse Model of Endometrial Carcinoma.

Authors:  Ingfrid S Haldorsen; Mihaela Popa; Tina Fonnes; Njål Brekke; Reidun Kopperud; Nicole C Visser; Cecilie B Rygh; Tina Pavlin; Helga B Salvesen; Emmet McCormack; Camilla Krakstad
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

10.  MUC1 positive, Kras and Pten driven mouse gynecologic tumors replicate human tumors and vary in survival and nuclear grade based on anatomical location.

Authors:  Tejas S Tirodkar; Raluca A Budiu; Esther Elishaev; Lixin Zhang; Jyothi T Mony; Joan Brozick; Robert P Edwards; Anda M Vlad
Journal:  PLoS One       Date:  2014-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.